Sector Update: Healthcare – Video

Posted by Dr. Michael White, Published on November 2nd, 2012

Sector Update: Healthcare
Shares of healthcare companies are lower ahead of the bell with Johnson Johnson (JNJ) and AstraZeneca Plc (AZN) reportedly stopping studies of experimental painkillers over concerns the new class of drugs may raise the risk of joint damage, Bloomberg reports. Endo Pharmaceutical Holdings (ENDP) said US regulators have approved its Fortesta gel as a treatment for hypogonadism or low testosterone. The company expects to launch Fortesta in the US early next year. St. Jude Medical (STJ) said it secured a new, $1.5 billion credit agreement with a group of lenders led by Bank of America (BAC), replacing a $1 billion loan package established in December 2006 used for general corporate purposes and to support its commercial paper program. Borrowing under the new pact running through 2015 will bear interest at LIBOR plus 0.875%, subject to revision if there #39;s a change in St. Jude #39;s credit rating.From:FinancialNewsOnlineViews:228 3ratingsTime:01:07More inNews Politics

View original post here:

Sector Update: Healthcare - Video

Contact Us Today

Enter Name (*)
Enter Email (*)
Enter Phone (*)
Select Program (*)
Select State (*)
Select your age (30+ only)
Confirm over 30 years old (*) Yes
Confirm USA Resident? (*) Yes
(*) - Required

After completing the contact form above, press the submit button. We will send you a confirmation email. Please check your email. For security purposes, please give us a call at 1-800-469-3343 if you don't receive an email.

best growth specialist natural hormone supplement.webp

Related Post

How useful was this post?

Click on a smiley face to rate it!

Average rating / 5. Vote count:

No votes so far! Be the first to rate this post.

Word Count: 167

Comments are closed.

testosterone chart testerone cream.webp
testosterone therapy.webp
low t test